NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS'B'DKK1 (NYSE: NVO)

Overview
current price
$59.43
$59.43
change
0.10 | 0.17%
0.10 | 0.17%
Yesterday's Close
59.33
open
59.27
volume
12.09 M
30d. avg volume.
21.18 M
1 day
58.59 - 59.91
52 weeks
43.08 - 93.80
p/e
0.00
beta
0.6723
market cap
201.48 B
dividend yield
2.07%
Industry
-
News and Commentary
Novo Nordisk Alzheimer's Miss Disappointing But Not Material, Analyst Says Novo Nordisk A/S (NVO&n...
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk Novo Nordisk's (NVO&nbs...
Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx President Donald Trump on Thursday announced agreements with Eli Lilly and Co.
Market Update: Dow Falls 400 Points as AI Stock Valuations Pressure Outlooks Stocks fell lower on Thursday as market participants grew more cautious over the high artificial intelligence stock valuations, which appear to be propping up the broader market....
Market Update: Stocks Fall as Valuations Remain Near All-Time Highs Stocks fell on Tuesday as investor sentiment turned cautious as market valuations continue to push towards record highs. The ongoing U.S. government shutdown is also impacting ou...
Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs? President Donald Trump just dropped a political bomb into one of Wall Street's hottest trades. His promise to cut the cost of Novo Nordisk A/S
Wegovy, Ozempic Maker Novo Nordisk Cuts Staff At Key US Production Sites Novo Nordisk A/S (NVO&n...
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.
Market Update: Stocks Decline Ahead of Fed Interest Rate Decision Stocks slipped on Tuesday as most market attention turned towards the Federal Reserve's upcoming policy decision on Wednesday as major averages trade around record highs.
Ozempic Is The New Botox And Big Pharma Is Printing Billions Ozempic and Zepbound have morphed from diabetes treatment into a cultural phenomenon, helping Novo Nordisk A/S
StockTwits
StockTwits

Join now and unlock premium features